These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7892748)

  • 1. Purified and cell-bound CD26: enzymatic inhibition, antibody binding profile, and expression on T cells in relation to other surface markers.
    Scharpe S; De Meester I
    Verh K Acad Geneeskd Belg; 1994; 56(6):537-59. PubMed ID: 7892748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.
    de Meester I; Scharpé S; Vanham G; Bosmans E; Heyligen H; Vanhoof G; Corte G
    Immunobiology; 1993 Jun; 188(1-2):145-58. PubMed ID: 8104877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
    Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
    J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of adenosine deaminase to the lymphocyte surface via CD26.
    De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
    Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J; Olek S; Fleischer B; von Bonin A
    Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro.
    Schön E; Jahn S; Kiessig ST; Demuth HU; Neubert K; Barth A; Von Baehr R; Ansorge S
    Eur J Immunol; 1987 Dec; 17(12):1821-6. PubMed ID: 2891539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
    Hegen M; Camerini D; Fleischer B
    Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.
    Hegen M; Niedobitek G; Klein CE; Stein H; Fleischer B
    J Immunol; 1990 Apr; 144(8):2908-14. PubMed ID: 1969875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV).
    Vivier I; Marguet D; Naquet P; Bonicel J; Black D; Li CX; Bernard AM; Gorvel JP; Pierres M
    J Immunol; 1991 Jul; 147(2):447-54. PubMed ID: 1712807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation.
    Kähne T; Kröning H; Thiel U; Ulmer AJ; Flad HD; Ansorge S
    Cell Immunol; 1996 May; 170(1):63-70. PubMed ID: 8660800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells.
    Hegen M; Mittrücker HW; Hug R; Demuth HU; Neubert K; Barth A; Fleischer B
    Immunobiology; 1993 Dec; 189(5):483-93. PubMed ID: 7907318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
    Subramanyam M; Gutheil WG; Bachovchin WW; Huber BT
    J Immunol; 1993 Mar; 150(6):2544-53. PubMed ID: 8095514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dipeptidyl peptidase IV from lymphocytes of chronic lymphocytic leukemia of T-type.
    Mentlein R; Rix H; Feller AC; Heymann E
    Biomed Biochim Acta; 1986; 45(5):567-74. PubMed ID: 2875712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
    Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
    Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
    Reinhold D; Kähne T; Steinbrecher A; Wrenger S; Neubert K; Ansorge S; Brocke S
    Biol Chem; 2002; 383(7-8):1133-8. PubMed ID: 12437097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system.
    Schön E; Eichmann E; Grunow R; Jahn S; Kiessig ST; Volk HD; Ansorge S
    Biomed Biochim Acta; 1986; 45(11-12):1523-8. PubMed ID: 2883967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound peptidases of lymphocytes: functional implications.
    Ansorge S; Schön E; Kunz D
    Biomed Biochim Acta; 1991; 50(4-6):799-807. PubMed ID: 1686972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidases of human lymphocytes.
    Lojda Z
    Czech Med; 1988; 11(4):181-94. PubMed ID: 2905980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
    van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
    Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.